Cooley

Firm overview:

Cooley draws on its well-established technology and life sciences focus, and strong IP and employment practices, to advise clients on trade secrets-related matters. The team handles high-stakes US and cross-border disputes for clients including IP-rich businesses, investors, and entrepreneurs.

Other services include auditing and strengthening restrictive covenants in employment agreements, investigating potential misappropriation, and developing synergistic patent and trade secret protection programmes. Demonstrating its thought leadership, Cooley’s US team regularly writes articles on the implications of the US Defend Trade Secrets Act and recent trade secrets decisions.

Team overview:

Heading up the IP litigation practice is Stephen Smith, who has a deep understanding of patents, trade secrets and technology-related issues, and has tried complex cases for some of the world’s leading technology companies in federal courts nationwide.

Another name to know at the firm for US trade secrets matters is Michael Sheetz, a first-chair trial lawyer who has acted as lead trial counsel in dozens of trade secrets cases across more than 20 states.

A significant departure from the team was that of Adam Gershenson, who left in October 2025 to join Weil, Gotshal & Manges. Gershenson co-chaired the firm’s issues and appeals practice group, as well as being a leader of the artificial intelligence (AI) task force.

The firm made some significant additions to the team over the past year, including adding seven partners to its global litigation department in San Francisco in June 2025. Simona Agnolucci, Benedict Hur, Joshua Anderson, Tiffany Lin, Jonathan Patchen, Michael Rome and Eduardo Santacana joined from Willkie Farr & Gallagher and are known for their expertise in high-stakes complex litigation, including bet-the-company commercial disputes, IP disputes and trade secrets theft, and more.

Key matters:

• Insulet v EOFlow et al

Cooley represents Korean insulin pump manufacturer EOFlow, defendant in a high-profile Massachusetts federal court case brought by Insulet, which accused its rivals of using its proprietary information in the EO Patch 2 pump.

In December 2024, a jury agreed with Insulet that EOFlow stole trade secrets and awarded $452 million in damages.

However, in April 2025, a US federal judge drastically reduced the award to $59.4 million.

In January 2026, the US Court of Appeals for the Federal Circuit heard oral arguments in EOFlow’s appeal of the US injunction, in which the company also took aim at the damages award.

Clients:

EOFlow